GSK
NEWS
The latest funding round gives XtalPi $20M in the bank, which the company said makes it “one of the top-funded AI-powered biotechs.”
This Latest move is a wide-ranging effort to boost competitiveness.
Speculation around a possible bid has mounted in recent months.
GlaxoSmithKline CEO Emma Walmsley is eying a big acquisition to spur revenue growth but is making sure that her company will not overpay.
GlaxoSmithKline CEO Emma Walmsley is not done reshaping her leadership team as she continues to overhaul the company’s pharmaceutical division.
Adaptimmune is making strides on becoming a fully integrated cell therapy company behind its T Cell Receptor technology
Vivek Ramaswamy’s Axovant has egg on its face after it was forced to own up to the fact it misreported mid-stage data on a drug it hoped to take into Phase III.
The company will undergo a reorganization that includes the termination of a number of sales representatives.
Under terms of the deal, Boehringer has the option to acquire Autifony’s Kv3.1/3.2 positive modulator platform, which includes the company’s lead compound AUT00206.
JOBS
IN THE PRESS